Percutaneous absorption in man: In vitro-in vivo correlation

Skin Pharmacology and Physiology

Volumn 24, Issue 4, 2011, Pages 224-230

  Lehman, P A ^a   Raney, S G ^a   Franz, T J ^a,b  

^a Cetero Research   (United States)

^b NONE   (United States)

Author keywords

Bioavailability; Bioequivalence; In vitro in vivo correlation; Percutaneous absorption

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; ACETYLSALICYLIC ACID; BENZENE; BENZOIC ACID; BORATE SODIUM; BORIC ACID; CAFFEINE; CHLORAMPHENICOL; CHLOROFORM; CHLORPYRIFOS; COUMARIN; DIMPYLATE; DISODIUM OCTABORATE; ECAMSULE; FLUAZIFOP BUTYL; HIPPURIC ACID; HYDROXYBIPHENYL; ISOFENPHOS; LINDANE; NICOTINAMIDE; NICOTINIC ACID; NITROBENZENE; PHENOL; PHENYLENEDIAMINE; PROPOXUR; SALICYLIC ACID; TESTOSTERONE; THIOUREA; UNCLASSIFIED DRUG; UNINDEXED DRUG; UREA;

ARTICLE; BIOEQUIVALENCE; CORRELATION ANALYSIS; DRUG ABSORPTION; DRUG BIOAVAILABILITY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; SKIN ABSORPTION;

HUMANS; MALE; PHARMACEUTICAL VEHICLES; PHARMACOKINETICS; SKIN; SKIN ABSORPTION; STATISTICS AS TOPIC;

EID: 79953172969     PISSN: 16605527     EISSN: 16605535     Source Type: Journal    
DOI: 10.1159/000324884     Document Type: Article

References (41)

1. Franz TJ, Lehman PA, Raney SG: The cadaver skin absorption model and the drug development process. Pharmacopeial Forum 2008;34:1349-1356.
2. Feldmann RJ, Maibach HI: Percutaneous penetration of steroids in man. J Invest Dermatol 1969;52:89-94.
3. Feldmann RJ, Maibach HI: Absorption of some organic compounds through the skin in man. J Invest Dermatol 1970;54:399-404.
4. Maibach HI, Feldmann RJ: Systemic absorption of pesticides through the skin of man; in Occupational Exposure to Pesticides. Report to the Federal Working Group on Pest Management from the Task Group on Occupational Exposure to Pesticides, Appendix B. Washington DC US Government Printing Office, 1975, pp 120-127.
5. Franz TJ: Percutaneous absorption: on the relevance of in vitro data. J Invest Dermatol 1975;64:190-195.
6. Franz TJ: The finite dose technique as a valid in vitro model for the study of percutaneous absorption in man; in Simon GA, Paster A, Klingberg MA, Kaye M (eds): Skin. Drug Application and Evaluation of Environmental Hazards. Curr Probl Dermatol. Basel, Karger, 1978, vol 7, pp 58-68.
7. Franz TJ: Percutaneous absorption of benzene; in MacFarland HM (ed): Applied Toxicology of Petroleum Hydrocarbons. Adv Modern Environ Toxicol. Princeton, Princeton Scientific, 1984, vol 6, pp 61-70.
8. Bronaugh RL, Maibach HI: Percutaneous absorption of nitroaromatic compounds: in vivo and in vitro studies in the human and monkey. J Invest Dermatol 1985;84:180-183. (Pubitemid 15127886)
9. Bronaugh RL, Franz TJ: Vehicle effect on percutaneous absorption: in vivo and in vitro comparisons. Br J Dermatol 1986;115:1-11. (Pubitemid 16090165)
10. Bucks DAW, McMaster JR, Maibach HI, Guy RH: Bioavailability of topically administered steroids: a 'mass balance' technique. J Invest Dermatol 1988;91:29-33.
11. Carmichael NG, Nolan RJ, Perkins JM, Dabies R, Warrington SJ: Oral and dermal pharmacokinetics of triclopyr in human volunteers. Hum Toxicol 1989;8:431-437. (Pubitemid 19271821)
12. Bucks DAW, Guy RH, Maibach HI: Percutaneous penetration and mass balance accountability: technique and implications for dermatology. J Toxicol Cutaneous Ocul Toxicol 1990;8:439-451. (Pubitemid 20274474)
13. Hotchkisssa M, Hewitt P, Caldwell J: Percutaneous absorption of nicotinic acid, phenol, benzoic acid and triclopyr butoxyethyl ester through rat and human skin in vitro: further validation of an in vitro model by comparison with in vivo data. Food Chem Toxicol 1992;30:891-899.
14. Ramsey JD, Woollen BH, Auton TR, Batten TR, Leeser PL: Pharmacokinetics of fluazifop-butyl in human volunteers. 2. Dermal dosing. Hum Exp Toxicol 1992;11:247-254.
15. Wester RC, Maibach HI, Melendres J, Sedik L, K naak J, Wa ng R: In vivo and in vitro percutaneous absorption and skin evaporation of isofenphos in man. Fundam Appl Toxicol 1992;19:521-526. (Pubitemid 23013122)
16. Wester RC, Sedik L, Melendres J, Logan F, Maibach HI, Russell I: Percutaneous absorption of d iazinon in hu ma ns. Food Chem Toxicol 1993;31:569-572.
17. Ramsey JD, Woollen BH, Auton TR, Scott RC: The predictive accuracy of in vitro measurements for the dermal absorption of a lipophilic penetrant (fluazifop-butyl) through rat and human skin. Fundam Appl Toxicol 1994;23:230-236. (Pubitemid 24277245)
18. 14 C-chloroform in humans. Hum Exp Toxicol 1995;14:260-265.
19. Franz TJ, Lehman PA, Franz SF, Guin JD: Comparative percutaneous absorption of lindane and permethrin. Arch Dermatol 1996;132:901-905. (Pubitemid 26266931)
20. Beckley-Kartey SAJ, Hotchkiss SAM, Capel M: Comparative in vitro skin absorption and metabolism of coumarin (1, 2-benzopyrone) in human, rat and mouse. Toxicol Appl Pharmacol 1997;145:34-42. (Pubitemid 27294767)
21. Dick IP, Blain PG, Williams FM: The percutaneous absorption and skin distribution of lindane in man. 2. In vitro studies. Hum Exp Toxicol 1997;16:652-657. (Pubitemid 27514099)
22. Wester RC, Hui X, Hartway T, Maibach HI, Bell K, Schell MJ, Northington DJ, Strong P, Culver BD: In vivo percutaneous absorption of boric acid, borax, and disodium octaborate tetrahydrate in humans compared to in vitro absorption in human skin from infinite and finite doses. Toxicol Sci 1998;45:42-51. (Pubitemid 28492237)
23. Griffin P, Mason H, Heywood K, Cocker J: Oral and dermal absorption of chlorpyrifos: a human volunteer study. Occup Environ Med 1999;56:1-10.
24. Griffin P, Payne M, Mason H, Freedlander E, Curran AD, Cocker J: The in vitro percutaneous penetration of chlorpyrifos. Hum Exp Toxicol 2000;19:104-107. (Pubitemid 30189871)
25. van de Sandt JJ, Meuling WJ, Elliott GR, Cnubben HH, Hakkert BC: Comparative in vitro-in vivo percutaneous absorption of the pesticide propoxur. Toxicol Sci 2000;58:15-22.
26. 14 C]coumarin by rats and by human volunteers under simulated conditions of use in fragrances. Food Chem Toxicol 2001;39:153-162. (Pubitemid 32239354)
27. Cnubben NHP, Elliott GR, Hakkert BC, Meuling WJA, van de Sandt JJM: Comparative in vitro-in vivo percutaneous penetration of the fungicide ortho-phenylphenol. Regul Toxicol Pharmacol 2002;35:198-208. (Pubitemid 34664920)
28. ® in human volunteers: comparison with in vitro data. Skin Pharmacol Appl Skin Physiol 2003;16:343-355. (Pubitemid 37256069)
29. van de Sandt JJM, van Burgsteden JA, Cage S, Carmichael PL, Dick I, Kenyon S, Korinth G, Larese F, Limasset JC, Maas WJM, Montomoli L, Nielsen JB, Payan JP, Robinson E, Sartorelli P, Schaller KH, Wilkinson SC, Williams FM: In vitro predictions of skin absorption of caffeine, testosterone, and benzoic acid: a multi-centre comparison study. Regul Toxicol Pharmacol 2004;39:271-281. (Pubitemid 38596765)
30. 14 C]-para-phenylenediamine-containing oxidative hair dye and correlation with in vitro percutaneous absorption in human or pig skin. Food Chem Toxicol 2004;42:1227-1236. (Pubitemid 38780869)
31. Modjtahedi BS, Maibach HI: In vivo percutaneous absorption of benzene in man: forearm and palm. Food Chem Toxicol 2008;46:1171-1174.
32. 14 C-cortisol in man. J Invest Dermatol 1967;48:181-183.
33. Wester RC, Maibach HI: Regional variation in percutaneous absorption: principles and applications to human risk assessment; in Bronaugh RL, Maibach HI (eds): Percutaneous Absorption. Drugs-Cosmetics-Mechanisms-Methodology. New York, Taylor & Francis, 2005, pp 85-93.
34. Barrett CD, Hadgraft JW, Sarkany I: The influence of vehicles on skin penetration. J Pharm Pharmacol 1964;16:104T-107T.
35. Sarkany I, Hadgraft JW, Caron GA, Barrett CW: The role of vehicles in the percutaneous absorption of corticosteroids. Br J Dermatol 1965;77:569-575.
36. Coldman WD, Poulsen BJ, Higuchi T: Enhancement of percutaneous absorption by the use of volatile:nonvolatile systems as vehicles. J Pharm Sci 1969;58:1098-1102.
37. Ostrenga J, Steinmetz C, Poulsen BJ: Significance of vehicle composition. 1. Relationship between topical vehicle composition, skin penetrability, and clinical efficacy. J Pharm Sci 1971;60:1175-1179.
38. Franz TJ: On the bioavailability of topical formulations of clindamycin hydrochloride. J Am Acad Dermatol 1983;9:66-73.
39. Bronaugh RL, Stewart RF: Methods for in vitro percutaneous absorption studies. 3. Hydrophobic compounds. J Pharm Sci 1984;73:1255-1258. (Pubitemid 14030714)
40. Organization for Economic Co-operation and Development (OECD): Guidance document for the conduct of skin absorption studies, Number 28. Paris, OECD, 2004.
41. Howes D, Guy R, Hadgraft J, Heylings J, Hoeck U, Kemper F, Maibach H, Marty J, Merk H, Parra J, Rekkas D, Rondelli I, Schaefer H, Tauber U, Verbiese N: Methods for assessing percutaneous absorption. European Centre for the Validation of Alternative Methods (ECVAM) Workshop Report 13. Altern Lab Anim 1996;24:81-106.